Delivery Order SPE2DB20D3101-SPE2DB25FRSH5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,743.18 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S pharmaceutical products. This non-competitive, firm fixed-price delivery order was awarded on September 8, 2025, with a completion date of September 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,349.80 to AmerisourceBergen Drug Corp for WIXELA 500-50 INHUB 60S, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $2,488.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 18, 2025, and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,231.35 for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child task order under AmerisourceBergen Drug Corp's larger contract vehicle with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,131.76 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of September 11, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through open competition to...
- The Defense Logistics Agency awarded a delivery order valued at $1,512.97 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product used in respiratory treatment. This firm fixed price delivery order, issued on April 29, 2025, with an ultimate completion date of April 30, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This delivery order, valued at $1,006.56, was awarded on September 18, 2025, to AmerisourceBergen Drug Corp for the supply of WIXELA 500-50 INHUB 60S, a pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation, issued by the Defense Logistics Agency (DLA), a defense agency component of the Department of Defense. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,948.02 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This delivery order, issued by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp $1,378.26 for the supply of Wixela 500-50 Inhub 60S, a pharmaceutical product, with completion scheduled for September 8, 2025. The contract employs firm fixed pricing and was competitively awarded without a set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,374.92 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count), with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing contract vehicle. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSH5Delivery Order
The Defense Logistics Agency awarded a $1,290.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for WIXELA 250-50 INHUB 60S, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 12, 2025. This is a non-set-aside, competitively awarded contract issued as a child delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's supply chain. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying contract structure reflects the DLA's Pharmaceutical Prime Vendor Global Program and allows AmerisourceBergen to serve multiple government healthcare customers, including the Defense Health Agency and U.S. Coast Guard, through a flexible procurement mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/11/25 |